发明名称 Low acidic species compositions
摘要 The instant invention relates to the field of protein production and purification, and in particular to compositions and processes for controlling the amount of charge variants, aggregates, and fragments of a protein of interest, as well as host cell proteins, present in purified preparations by applying particular chromatography conditions during such protein purification.
申请公布号 US9334319(B2) 申请公布日期 2016.05.10
申请号 US201313829989 申请日期 2013.03.14
申请人 AbbVie Inc. 发明人 Ramasubramanyan Natarajan;Yang Lihua;Herigstad Matthew Omon;Yang Hong;Chumsae Christopher
分类号 C07K16/00;C12P21/08;A61K39/395;C07K16/24;C07K1/16;C07K1/18;C12P21/00;C07K1/20;C07K1/22 主分类号 C07K16/00
代理机构 McCarter & English, LLP 代理人 McCarter & English, LLP ;Zacharakis Maria Laccotripe;Tyner Lisa
主权项 1. A composition comprising adalimumab, wherein the composition comprises less than 10% total acidic species of adalimumab, wherein the acidic species of adalimumab correspond to the peaks that elute earlier than the main peak in a WCX-10 HPLC chromatogram of adalimumab, wherein the WCX-10 HPLC chromatogram is generated using a first mobile phase of 10 mM Sodium Phosphate dibasic (pH 7.5) and a second mobile phase of 10 mM Sodium Phosphate dibasic, 500 mM Sodium Chloride (pH 5.5), and wherein the WCX-10 HPLC chromatogram is generated using detection at 280 nm.
地址 North Chicago IL US